ROYAL BANK OF CANADA - SYNAGEVA BIOPHARMA CORP ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$38,000
-60.4%
390
-62.2%
0.00%
Q4 2014$96,000
+35.2%
1,0320.0%0.00%
Q3 2014$71,000
+153.6%
1,032
+137.2%
0.00%
Q3 2013$28,0004350.00%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 9,223,182$387,189,0007.66%
EMERALD MUTUAL FUND ADVISERS TRUST 78,486$3,295,0000.56%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,485,288$104,382,0000.46%
HARVEY CAPITAL MANAGEMENT INC 34,800$1,460,0000.45%
EMERALD ADVISERS, LLC 148,232$6,223,0000.38%
DRIEHAUS CAPITAL MANAGEMENT LLC 148,411$6,233,0000.27%
ArrowMark Colorado Holdings LLC 15,500$651,0000.18%
CR Intrinsic Investors, LLC 118,161$4,963,0000.17%
BB BIOTECH AG 53,549$2,248,0000.16%
TURNER INVESTMENTS LLC 209,744$8,806,0000.12%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders